Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Adult Liver Cancer”

650 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 650 results

Testing effectiveness (Phase 2)UnknownNCT00691691
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors

Who this might be right for
Liver Tumors
Alberta Health services 71
Testing effectiveness (Phase 2)UnknownNCT04826406
What this trial is testing

Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint Inhibitors
Hunan Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00987935
What this trial is testing

A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

Who this might be right for
Carcinoma, Hepatocellular
Boehringer Ingelheim 134
Testing effectiveness (Phase 2)UnknownNCT05603039
What this trial is testing

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Liver Cancer
Qilu Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT05171309
What this trial is testing

Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 35
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Testing effectiveness (Phase 2)Ended earlyNCT00862082
What this trial is testing

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Proacta, Incorporated 14
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT04798781
What this trial is testing

Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma

Who this might be right for
Gastric CancerHepatocellular Carcinoma
Andrew Hendifar, MD 16
Testing effectiveness (Phase 2)Looking for participantsNCT06870942
What this trial is testing

Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy

Who this might be right for
HCC - Hepatocellular CarcinomaRadiotherapy
Shanghai Zhongshan Hospital 35
Testing effectiveness (Phase 2)Study completedNCT04444167
What this trial is testing

Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Akeso 59
Testing effectiveness (Phase 2)Study completedNCT05517239
What this trial is testing

Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Who this might be right for
Hepatocellular Carcinoma, Unresectable, Advanced
Yonsei University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06812039
What this trial is testing

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Who this might be right for
Hepato Cellular Carcinoma (HCC)
Fudan University 165
Testing effectiveness (Phase 2)Study completedNCT00056992
What this trial is testing

Testing of ADI-PEG in Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
FDA Office of Orphan Products Development 34
Testing effectiveness (Phase 2)UnknownNCT05578430
What this trial is testing

AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Who this might be right for
Resectable Hepatocellular Carcinoma
Sun Yat-sen University 54
Testing effectiveness (Phase 2)Study completedNCT00242502
What this trial is testing

Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT00933816
What this trial is testing

Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy

Who this might be right for
Hepatocellular Carcinoma
Kindai University 37
Testing effectiveness (Phase 2)Study completedNCT01545804
What this trial is testing

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
National Taiwan University Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Ended earlyNCT02575339
What this trial is testing

MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerHCC
Kathy Miller 11
Load More Results